NextCure, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NextCure, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • NextCure, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 16.5 %, a 64.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 16.5 +6.46 +64.6% Sep 30, 2024
Q2 2024 14.2 +5.85 +70.1% Jun 30, 2024
Q1 2024 12.2 +5.49 +82.4% Mar 31, 2024
Q4 2023 10.4 +4.91 +89% Dec 31, 2023
Q3 2023 10 +5.85 +141% Sep 30, 2023
Q2 2023 8.34 +4.36 +110% Jun 30, 2023
Q1 2023 6.67 +2.58 +63.2% Mar 31, 2023
Q4 2022 5.52 +1.4 +34% Dec 31, 2022
Q3 2022 4.15 -0.09 -2.12% Sep 30, 2022
Q2 2022 3.98 +0.03 +0.76% Jun 30, 2022
Q1 2022 4.08 +0.34 +9.08% Mar 31, 2022
Q4 2021 4.12 +0.53 +14.8% Dec 31, 2021
Q3 2021 4.25 -0.95 -18.3% Sep 30, 2021
Q2 2021 3.95 -4.11 -50.9% Jun 30, 2021
Q1 2021 3.75 -7.76 -67.5% Mar 31, 2021
Q4 2020 3.58 -19 -84.1% Dec 31, 2020
Q3 2020 5.2 -49.8 -90.5% Sep 30, 2020
Q2 2020 8.07 Jun 30, 2020
Q1 2020 11.5 Mar 31, 2020
Q4 2019 22.6 Dec 31, 2019
Q3 2019 55 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.